跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 29 条关于
“Cabaletta”
全部
29
临床试验
3
药物
2
机构
1
资讯
23
2年前
Cabaletta Bio's CABA-201 Receives FDA Orphan Drug Designation for Idiopathic Inflammatory Myopathies
7个月前
Cabaletta Bio Receives FDA Clearance for Automated CAR-T Manufacturing Platform
去年
Cabaletta Bio Advances CABA-201 Trials, Expands to Europe, and Reports $183M Cash Position
去年
Cabaletta Bio Advances RESET Program for Autoimmune Diseases; Reports Q3 2024 Financials
去年
Cabaletta Bio's Rese-cel Shows Promising Safety and Efficacy in Autoimmune Disease Trials
11个月前
Cabaletta Bio Appoints Steve Gavel as Chief Commercial Officer to Lead CAR-T Therapy Launch
去年
Cabaletta Bio Announces Positive Clinical Updates for CABA-201 in Autoimmune Diseases
11个月前
Cabaletta Bio's CAR-T Therapy Shows Promise Without Preconditioning in Pemphigus Vulgaris Trial
去年
Cabaletta Bio to Present New CABA-201 Clinical Data at ACR Convergence 2024
去年
Cabaletta Bio Launches Public Offering to Fund CAR-T Cell Therapy Development for Autoimmune Diseases
第 1 页,共 3 页
上一页
下一页